0 01/01/2025 31/12/2025 2025-12-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2025-01-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 13943321 2025-01-01 2025-12-31 13943321 2025-12-31 13943321 2024-12-31 13943321 2024-01-01 2024-12-31 13943321 2024-12-31 13943321 2023-12-31 13943321 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 13943321 bus:Director1 2025-01-01 2025-12-31 13943321 bus:Micro-entities 2025-01-01 2025-12-31 13943321 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 13943321 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 13943321 bus:CompanyLimitedByGuarantee 2025-01-01 2025-12-31 13943321 bus:FullAccounts 2025-01-01 2025-12-31
Company registration number: 13943321
Stem Cell Education and Research
Company limited by guarantee
Unaudited filleted financial statements
31 December 2025
Stem Cell Education and Research
Company limited by guarantee
Contents
Accountants report
Statement of financial position
Stem Cell Education and Research
Company limited by guarantee
Report to the director on the preparation of the
unaudited statutory financial statements of Stem Cell Education and Research
Year ended 31 December 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Stem Cell Education and Research for the year ended 31 December 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.
This report is made solely to the director of Stem Cell Education and Research, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Stem Cell Education and Research and state those matters that we have agreed to state to them, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Stem Cell Education and Research and its director as a body for our work or for this report.
It is your duty to ensure that Stem Cell Education and Research has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Stem Cell Education and Research. You consider that Stem Cell Education and Research is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Stem Cell Education and Research. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Curnow & Co Limited
Chartered Certified Accountants
Brackenhurst
Lee
Ilfracombe
EX34 8LW
16 March 2026
Stem Cell Education and Research
Company limited by guarantee
Statement of financial position
31 December 2025

|  |  | 2025 |  |  | 2024 |
|  |  | £ | £ |  | £ | £
Fixed assets |  |  |  | 387 |  |  | 516
|  |  |  | _______ |  |  | _______
Current assets |  |  | 40,366 |  |  | 32,401 |
Prepayments and accrued income |  |  | 12,185 |  |  | 8,300 |
|  |  | _______ |  |  | _______ |
|  |  |  | 52,551 |  |  | 40,701
Net current assets |  |  |  | 52,551 |  |  | 40,701
|  |  |  | _______ |  |  | _______
Total assets less current liabilities |  |  |  | 52,938 |  |  | 41,217
Accruals and deferred income |  |  |  | ( 720) |  |  | ( 720)
|  |  |  | _______ |  |  | _______
Net assets |  |  |  | 52,218 |  |  | 40,497
|  |  |  | _______ |  |  | _______
Capital and reserves |  |  |  | 52,218 |  |  | 40,497
|  |  |  | _______ |  |  | _______

Stem Cell Education and Research
Company limited by guarantee
Year ended 31 December 2025
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 16 March 2026 , and are signed on behalf of the board by:
Professor A. G. Smith
Director
Company registration number: 13943321
The company is a private company limited by guarantee, registered in England. The address of the registered office is Flat 1, 19 Victoria Park Road, St Leonards, Exeter, EX2 4NT.